Thomas Charles Reilly Amarin Corp Plcuk (AMRN) insider trading activity

Thomas Charles Reilly is EVP and CFO of AMARIN CORP PLCUK. Currently has a direct ownership of 94,305 shares of AMRN, which is worth approximately $43,380. The most recent transaction as insider was on Jul 01, 2024, when has been sold 8,209 shares (Ordinary Shares) at a price of $0.69 per share, resulting in proceeds of $5,664. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 94.3K

0% 3M change

271.65% 12M change

Total Value Held $43,380

Thomas Charles Reilly Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 01 2024	SELL Payment of exercise price or tax liability	$5,664 $0.69 p/Share	8,209 Reduced 8.01%	94,305 Ordinary Shares
Jul 01 2024	BUY Exercise of conversion of derivative security	-	16,667 Added 13.98%	102,514 Ordinary Shares
Jun 20 2024	SELL Payment of exercise price or tax liability	$11,984 $0.73 p/Share	16,417 Reduced 16.05%	85,847 Ordinary Shares
Jun 20 2024	BUY Exercise of conversion of derivative security	-	33,333 Added 24.58%	102,264 Ordinary Shares
Jan 31 2024	SELL Payment of exercise price or tax liability	$30,444 $1.24 p/Share	24,552 Reduced 26.26%	68,931 Ordinary Shares
Jan 31 2024	BUY Exercise of conversion of derivative security	-	44,933 Added 32.46%	93,483 Ordinary Shares
Jan 10 2024	SELL Payment of exercise price or tax liability	$27,475 $0.97 p/Share	28,325 Reduced 36.85%	48,550 Ordinary Shares
Jan 10 2024	BUY Exercise of conversion of derivative security	-	51,500 Added 40.12%	76,875 Ordinary Shares
Jul 01 2023	SELL Payment of exercise price or tax liability	$9,768 $1.19 p/Share	8,209 Reduced 24.44%	25,375 Ordinary Shares
Jul 01 2023	BUY Exercise of conversion of derivative security	-	16,667 Added 33.17%	33,584 Ordinary Shares
Jun 20 2023	SELL Payment of exercise price or tax liability	$19,536 $1.19 p/Share	16,417 Reduced 49.25%	16,917 Ordinary Shares
Jun 20 2023	BUY Exercise of conversion of derivative security	-	33,334 Added 50.0%	33,334 Ordinary Shares

Also insider at

CARA

Cara Therapeutics, Inc. Healthcare

Chief Financial Officer

TCR